COWAN CHAD (Chief Scientific Officer) purchased 5.9% of their position (58.06K shares) of CENTURY THERAPEUTICS, INC. on the open market
Open‑market purchase worth $49.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/29/2025ACC: 0002039294-25-000008
Officer· Chief Scientific Officer
Since Mar 2026
+58.06K
Net shares
Net buyer
$49.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
58.06K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+58.06K
Price / share
$0.85
Trade value
$49.25K
% of position
5.9%
12/22/2025
987.03K→1.05M
Total
Net shares
+58.06K
Net value
$49.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2025 | P · Purchase | +58.06K | $0.85 | $49.25K | 5.9% | 987.03K | 1.05M |
| Total | +58.06K | $49.25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned10.70K
Total
10.70K indirect10.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.70K | Indirect |
| Total | 10.70K | 10.70K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported